Reply to: Graefe-Mody U, Friedrich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939-946

Journal article

B. Snyder, T. M. Polasek and M. P. Doogue

Diabetes, obesity & metabolism, Vol.14(7), pp.670-670

07/2012

Handle:

https://hdl.handle.net/10523/37507

Abstract

Endocrinology & Metabolism

Life Sciences & Biomedicine

Science & Technology

11 Record Views

Record Identifier: 9926530211201891
Title: Reply to: Graefe-Mody U, Friedrich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939-946
Creators: B. Snyder
T. M. Polasek
M. P. Doogue
Publication Details: Diabetes, obesity & metabolism, Vol.14(7), pp.670-670
Academic Unit: Medicine (UOC)
Publisher: Wiley
Date published ; e-published: 07/2012
Language: English
Resource Type ; Subtype: Journal article